Stratipath co-founder Professor Johan Hartman, is discussing the future of precision diagnostics in Medtech Magazine

“Stratipath Breast is the first solution of its kind in the world that can provide prognostic information, predicting outcomes for breast cancer patients. Previous technologies were based on gene expression, but few patients had access to those analysis methods. With AI, you can achieve much greater accessibility and faster results.” / Johan Hartman, MedTech magazine.